These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29183160)

  • 1. Daily spirometry in an acute exacerbation of adult cystic fibrosis patients.
    Stephen MJ; Long A; Bonsall C; Hoag JB; Shah S; Bisberg D; Holsclaw D; Varlotta L; Fiel S; Du D; Zanni R; Hadjiliadis D
    Chron Respir Dis; 2018 Aug; 15(3):258-264. PubMed ID: 29183160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis.
    VanDevanter EJ; Heltshe SL; Skalland M; Lechtzin N; Nichols D; Goss CH
    J Cyst Fibros; 2021 Nov; 20(6):932-936. PubMed ID: 33685776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic duration and changes in FEV
    Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
    BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
    Somayaji R; Russell R; Cogen JD; Goss CH; Nick SE; Saavedra MT; Taylor-Cousar JL; Nick JA; Nichols DP
    Ann Am Thorac Soc; 2019 Jul; 16(7):853-860. PubMed ID: 30840835
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous antibiotic use and exacerbation events in an adult cystic fibrosis centre: A prospective observational study.
    Hoo ZH; Bramley NR; Curley R; Edenborough FP; Walters SJ; Campbell MJ; Wildman MJ
    Respir Med; 2019; 154():109-115. PubMed ID: 31234038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations.
    VanDevanter DR; O'Riordan MA; Blumer JL; Konstan MW
    Respir Res; 2010 Oct; 11(1):137. PubMed ID: 20925941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CF.
    Hoo ZH; Wildman MJ; Curley R; Walters SJ; Campbell MJ
    Respirology; 2018 Feb; 23(2):190-197. PubMed ID: 28905459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.
    Sequeiros IM; Jarad N
    Chron Respir Dis; 2012 Feb; 9(1):9-16. PubMed ID: 22308550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home-spirometry exacerbation profiles in children with cystic fibrosis.
    Bouteleux B; Beaufils F; Fayon M; Bui S
    Pediatr Pulmonol; 2024 Mar; 59(3):552-561. PubMed ID: 38014613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do cystic fibrosis centres with the lowest FEV
    Hoo ZH; Campbell MJ; Curley R; Walters SJ; Wildman MJ
    J Cyst Fibros; 2018 May; 17(3):360-367. PubMed ID: 29074367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An impulse oscillometry system is less efficient than spirometry in tracking lung function improvements after intravenous antibiotic therapy in pediatric patients with cystic fibrosis.
    Buchs C; Coutier L; Vrielynck S; Jubin V; Mainguy C; Reix P
    Pediatr Pulmonol; 2015 Nov; 50(11):1073-81. PubMed ID: 26340567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations.
    Sequeiros IM; Jarad NA
    Chron Respir Dis; 2012; 9(4):213-20. PubMed ID: 22637747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
    West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
    J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
    Heltshe SL; Goss CH; Thompson V; Sagel SD; Sanders DB; Marshall BC; Flume PA
    Thorax; 2016 Mar; 71(3):223-9. PubMed ID: 25911223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
    Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
    J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
    Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
    J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Impulse Oscillometry System a Useful Method for the Evaluation and Follow-Up of Patients with Cystic Fibrosis?
    Kartal Öztürk G; Eşki A; Gülen F; Demir E
    Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):15-22. PubMed ID: 33734877
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).
    Frost F; Young GR; Wright L; Miah N; Smith DL; Winstanley C; Walshaw MJ; Fothergill JL; Nazareth D
    J Cyst Fibros; 2021 Nov; 20(6):994-1002. PubMed ID: 33358119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.